Public procurement is a process by which a government purchases goods from the private sector to meet state and municipal needs whilst paying from budgetary or non-budgetary funds.
Only the 10 leading pharmaceutical companies are presented.
Citation formats
Oncology drug procurement market share in Russia H1 2022, by company
In the first half of 2022, the Swiss company Roche yielded over ** percent of the total oncology drug revenue acquired via public procurement in Russia. The Russian company Biocad closely followed, with a share of ** percent. The total revenue earned by manufacturers from cancer drug sales in Russia was estimated at*** billion U.S. dollars in 2022.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Vmeste Protiv Raka. (August 4, 2022). Share of total oncology drug revenue earned from public procurement in Russia in 1st half 2022, by leading manufacturer [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved August 03, 2026, from /statistics/1385977/russia-top-pharma-companies-by-oncology-revenue-share/
Vmeste Protiv Raka. "Share of total oncology drug revenue earned from public procurement in Russia in 1st half 2022, by leading manufacturer." Chart. August 4, 2022. ÌÇÐÄÆƽâ°æ. Accessed August 03, 2026. /statistics/1385977/russia-top-pharma-companies-by-oncology-revenue-share/
Vmeste Protiv Raka. (2022). Share of total oncology drug revenue earned from public procurement in Russia in 1st half 2022, by leading manufacturer. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: August 03, 2026. /statistics/1385977/russia-top-pharma-companies-by-oncology-revenue-share/
Vmeste Protiv Raka. "Share of Total Oncology Drug Revenue Earned from Public Procurement in Russia in 1st Half 2022, by Leading Manufacturer." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 4 Aug 2022, /statistics/1385977/russia-top-pharma-companies-by-oncology-revenue-share/
Vmeste Protiv Raka, Share of total oncology drug revenue earned from public procurement in Russia in 1st half 2022, by leading manufacturer ÌÇÐÄÆƽâ°æ, /statistics/1385977/russia-top-pharma-companies-by-oncology-revenue-share/ (last visited August 03, 2026)
Share of total oncology drug revenue earned from public procurement in Russia in 1st half 2022, by leading manufacturer [Graph], Vmeste Protiv Raka, August 4, 2022. [Online]. Available: /statistics/1385977/russia-top-pharma-companies-by-oncology-revenue-share/
